Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore

Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Nov 7, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on helping Black women who have experienced intimate partner violence and are seeking support from domestic violence services. The study aims to create and test a decision aid that helps these women understand and access pre-exposure prophylaxis (PrEP), a medication that can help prevent HIV. Researchers are trying out three different ways to provide this information: individually, with the help of a domestic violence advocate, or through general information. The goal is to make sure the decision aid respects the unique challenges these women face and empowers them to make informed choices about their health.

To participate in this study, women must be at least 18 years old, identify as cisgender females, and have experienced some form of intimate partner violence in the past year. They should also be HIV negative, speak English or Spanish, and identify as Black or African American. Participants will receive tailored information about PrEP and have the chance to share their thoughts and experiences regarding this important health issue. This study is currently recruiting participants, and it's a great opportunity for women who meet the criteria to gain valuable knowledge and support.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • age 18 years or older
• • self-identification as cisgender female
• • IPV-exposed (i.e., at least one physical, sexual, or psychological IPV victimization experience by a male partner) in the past 12 months
• • self-reported HIV negative
• • English- and/or Spanish-speaking
• • self-identify as Black or African American
• Exclusion Criteria:
• • Currently using PrEP
• • Unable to provide consent
• • Participated in formative research for this study